Concepedia

Evelyn M. Flahavan

EM

11

Publications

286

Citations

10

H-Index

1973

Active since

Affiliations

Trinity College Dublin(Current)

Roche (United Kingdom)

National Cancer Registry

Roche (Switzerland)

AbbVie (United States)

Evelyn M. Flahavan is an author at Trinity College Dublin specializing in medicine, pharmacotherapy, and oncology.

ORCID

Top concepts

Publications per year

1973–2023

11

Publications

11

A cohort study investigating aspirin use and survival in men with prostate cancer

Evelyn M. Flahavan, Kathleen Bennett, Linda Sharp et al. · Annals of Oncology · 2013 · 52 citations

, , +6

Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US

Pankit Vachhani, Evelyn M. Flahavan, Tao Xu et al. · The Oncologist · 2022 · 44 citations · Full text

Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I–III Breast Cancer: A Nationwide Population-Based Cohort Study

Thomas I. Barron, Evelyn M. Flahavan, Linda Sharp et al. · Cancer Research · 2014 · 37 citations · Full text

Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink

Chris R. Cardwell, Evelyn M. Flahavan, Carmel Hughes et al. · Cancer Causes & Control · 2013 · 31 citations

, , +4

A cohort study of digoxin exposure and mortality in men with prostate cancer

Evelyn M. Flahavan, Linda Sharp, Kathleen Bennett et al. · British Journal of Urology · 2013 · 25 citations

Rows per page

1–5 of 11